logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Turning Point Therapeutics, Inc.


USPTO Granted Patents = 19


Trademarks = 3

Forward Citations = 28

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Jingrong Jean Cui (19 out of 45 patents)

silverMedal Dayong Zhai (18 out of 22 patents)

bronzeMedal Evan W Rogers (16 out of 47 patents)

4.  Wei Deng (13 out of 14 patents)

5.  Jane Ung (10 out of 19 patents)

6.  Yishan Li (7 out of 10 patents)

7.  Jeffrey Whitten (6 out of 6 patents)

8.  Zhongdong Huang (6 out of 6 patents)

9.  Han Zhang (6 out of 6 patents)

10.  Xin Zhang (4 out of 5 patents)

11.  Jing Liu (4 out of 26 patents)

12.  Vivian Nguyen (2 out of 2 patents)

13.  Brion William Murray (2 out of 10 patents)

14.  Laura Rodon (2 out of 2 patents)

15.  Nathan V Lee (1 out of 1 patent)


19 patents:

1. 12606571 - Macrocyclic compounds and uses thereof (2026-04-21),
2. RE50634 - Diaryl macrocycles as modulators of protein kinases (2025-10-14),
3. 12404281 - Diaryl macrocycles as modulators of protein kinases (2025-09-02),
4. 12310968 - Chiral diaryl macrocycles and uses thereof (2025-05-27),
5. 12187739 - Diaryl macrocycle polymorph (2025-01-07),
6. 11981684 - Macrocyclic compounds and uses thereof (2024-05-14),
7. 11666574 - Combination therapy involving diaryl macrocyclic compounds (2023-06-06),
8. 11654145 - Combination therapy involving diaryl macrocyclic compounds (2023-05-23),
9. 11634433 - Macrocycles for use in treating disease (2023-04-25),
10. 11452725 - Chiral diaryl macrocycles and uses thereof (2022-09-27),
11. 11291667 - Combination therapy involving diaryl macrocyclic compounds (2022-04-05),
12. 11286265 - Macrocyclic compounds for treating disease (2022-03-29),
13. 11286264 - Macrocyclic compounds and uses thereof (2022-03-29),
14. 11155563 - Macrocyclic compounds and uses thereof (2021-10-26),
15. 11142533 - Macrocycles for use in treating disease (2021-10-12),
Company Overview
Turning Point Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer treatment. The company specializes in targeted drug discovery and development, particularly in the area of precision medicine. By leveraging advanced research methodologies, Turning Point aims to address unmet medical needs in oncology, providing potential solutions for patients with specific genetic mutations and other biomarkers. Their commitment to scientific excellence drives their efforts in creating effective therapeutic options.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Turning Point Therapeutics, Inc. USPTO Patent Assignee Logo
19 Patents

#313 in San Diego, CA

#4,099 in California

#17,138 in US

#32,663 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Turning Point Therapeutics, Inc.

Forward Citations = 28

15 inventors:

goldMedal Jingrong Jean Cui (19 out of 45 patents)

silverMedal Dayong Zhai (18 out of 22 patents)

bronzeMedal Evan W Rogers (16 out of 47 patents)

4.  Wei Deng (13 out of 14 patents)

5.  Jane Ung (10 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Turning Point Therapeutics, Inc.. Retrieved from https://idiyas.com/company/turning-point-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…